FDA Approves Dupixent for Chronic Obstructive Pulmonary Disease
Approval is the first in the U.S. for a biologic for the condition
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Approval is the first in the U.S. for a biologic for the condition
Only registered members have full access to PracticeUpdate content.